[A case of advanced colon cancer responding completely to systemic 5-fluorouracil/l-leucovorin therapy]. 2004

Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
Dept. of Surgery, Rinku General Medical Center, Izumisano Municipal Hospital.

A 79-year-old man was admitted for advanced transverse colon cancer with large bowel obstruction. Twelve years earlier he underwent a total gastrectomy with Roux-en Y reconstruction for gastric cancer. No metastasis was detected preoperatively. Exploratory laparotomy revealed massive direct invasion of the mesenterium of the jejunum for Roux-en Y reconstruction. The primary lesion was unresected and transverse colostomy was made. Systemic chemotherapy with 5-fluorouracil and l-leucovorin was scheduled for a total of 4 courses postoperatively. After completion of this chemotherapeutic regimen, a CT scan and colonofiberscopy revealed the primary lesions had disappeared, and a histological examination of biopsy confirmed that the patient had achieved a complete remission (CR). There was no severe side effect during chemotherapy. The patient is presently enjoying a good general condition and has been free from any sign of recurrence.

UI MeSH Term Description Entries
D008297 Male Males
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003125 Colostomy The surgical construction of an opening between the colon and the surface of the body. Colostomies
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
July 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
January 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
September 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
December 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
May 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
February 2003, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
April 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
November 2013, Gan to kagaku ryoho. Cancer & chemotherapy,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
September 2003, Nihon rinsho. Japanese journal of clinical medicine,
Tsunekazu Mizushima, and Kinya Sando, and Toshikazu Ito, and Shoki Mikata, and Kentaro Nonaka, and Haruki Ide, and Toshiya Michiura, and Satoshi Kainuma, and Hiroaki Yamanaka, and Kazuhiro Iwase
January 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!